"The Future of Robotic Surgery," over 400 medical specialists gathered to participate in a dynamic exchange of ideas and insights. The ...
The EVAQ Trial enrolled 121 patients at 17 centers globally. Data from the study will be used as part of an application to the U.S. Food and Drug Administr...
All India Institute of Medical Sciences (AIIMS) New Delhi and India Medtronic, a wholly owned subsidiary of Ireland-based Medtronic plc, has announced the ...
NANO-X IMAGING LTD ("Nanox" or the "Company," Nasdaq: NNOX), an innovative medical imaging technology company, today announced that it has received a ...
"Our shared vision is one program offered at two sites to provide patients with the right care in a location close to home," said Dr. Glen Van Arsdell, who...
These new patents complement the company's strong international portfolio of 20 families and more than 78 patents covering the concept, design, production ...
Indica Labs, an industry leader in quantitative digital pathology and image management innovations, and Lunit, a leading medical AI software platform compa...
QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) announced today that its QIAstat-Dx syndromic testing solution is expected to be available soon for use ...
Currently, up to 50% of people die within 30 days of an ICH, Highlighting the Need for New Options1 NICO Corporation, a pioneer and lea...
Medtronic plc (NYSE: MDT), the global leader in medical technology, today announced U.S. Food and Drug Administration (FDA) approval of its Mini...
This survey found that the majority of endoscopists currently find it difficult to measure polyps accurately, with nearly three quarters stating that there...
As part of this initiative, Segmed will offer synthetic medical imaging data on their self-serve medical data curation platform, Segmed Insight. This is in...
Bridging the gap between histopathology and molecular pathology Xyall and Indica Labs have entered into a global strategic partnership designed to bridge ...
OM1, a leading real-world data, outcomes and technology company with a focus on chronic conditions, today launched PhenOM™, its artificial intelligen...
© 2025 Biopharma Boardroom. All Rights Reserved.
